Opportunity
SAM #HT941026N0123
Sole Source Notice – Oncotype DX Cancer Testing Services for Mike O’Callaghan Military Medical Center
Buyer
Defense Health Agency
Posted
September 07, 2026
Respond By
September 11, 2026
Identifier
HT941026N0123
NAICS
621511
This notice announces the Defense Health Agency's intent to award a sole-source contract for cancer testing services at Mike O’Callaghan Military Medical Center, Nellis AFB. - Agency: Defense Health Agency, Healthcare Contracting Division–West - Vendor: Genomic Health, Inc. (an Exact Sciences company) - Product/Service: Oncotype DX branded genomic tumor-testing service and associated report - Includes specimen submission materials, testing at contractor's facility, written results and interpretation, and return of tissue tumor blocks or slides - Sole-source justification: Genomic Health, Inc. is the only vendor specified for Oncotype DX testing - Contract structure: Firm-fixed-price, base year plus four 12-month option periods, and a possible six-month extension - NAICS code: 621511; PSC: Q301 - Not a competitive solicitation; capability statements from interested sources are invited
Description
The Defense Health Agency Contracting Activity, Healthcare Contracting Division–West, intends to negotiate and award a firm-fixed-price sole-source contract to Genomic Health, Inc., an Exact Sciences company, for Oncotype DX Cancer Testing Services in support of Mike O’Callaghan Military Medical Center, Nellis AFB, Nevada.
The requirement is for the specific Oncotype DX branded genomic tumor-testing service and associated report for eligible patients. The contractor shall provide materials necessary for specimen submission, perform required testing at the contractor’s facility, provide written test results and interpretation, and return tissue tumor blocks or unstained slides in accordance with the resulting contract.
The anticipated period of performance is 16 September 2026 through 15 September 2027, with four 12-month option periods and a potential six-month extension. This is a Notice of Intent to Sole Source and is not a request for competitive quotations or proposals. Interested sources may submit a capability statement by the response deadline stated in this notice.